-- AltaGas (ALA.TO) 週四公佈第一季經調整淨利成長,並表示預計將實現 2026 年業績預期上限。 經調整淨利為 4.15 億加元,合每股 1.33 美元,高於去年同期的 3.42 億加元,每股 1.14 美元。該業績超過了 FactSet 匯總的非 GAAP 每股收益預期 1.24 美元。 營收與去年同期持平,為 39.7 億美元。該業績低於 FactSet 匯總的 41.3 億美元的銷售額預期。 經調整 EBITDA 為 8.18 億美元,高於去年同期的 6.89 億美元。 經調整 EBITDA 的成長主要歸功於全球出口量和利潤率的提高、加工和液體處理利潤率的增強、華盛頓特區和維吉尼亞州新的公用事業費率、強勁的資產優化以及部分退休金負債的結算。 AltaGas預計2026年調整後EBITDA和調整後每股盈餘將接近預期上限,液化石油氣市場持續強勁成長可望帶來額外收益。 公司重申2026年調整後EBITDA預期為19.25億美元至20.25億美元;調整後每股盈餘預期為2.20美元至2.45美元。 公司將2026年資本支出計畫增加至17億美元。
Related Articles
BNP Paribas Adjusts Price Target on Ingersoll Rand to $82 From $94
Ingersoll Rand (IR) has an average rating of overweight and mean price target of $96.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $77.89, Change: $+0.43, Percent Change: +0.56%
Mizuho Adjusts Price Target on Humana to $290 From $258
Humana (HUM) has an average rating of hold and mean price target of $228.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $242.12, Change: $-1.00, Percent Change: -0.41%
Jefferies Adjusts Price Target on Humana to $290 From $235
Humana (HUM) has an average rating of hold and mean price target of $228.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $242.12, Change: $-1.00, Percent Change: -0.41%